Orion PharmaDHA:ORIONPHARM +0.33%71 OCF Yield % is 11.44 as of Jul. 12, 2026, which is 22% below its 10-year median of 14.69. GuruFocus rates DHA:ORIONPHARM with a GF Score™ of 71/100 and a GF Value™ of BDT20.19 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 439 Utilities - Independent Power Producers companies, Orion Pharma ranks better than 59.68% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Orion Pharma's OCF Yield % or its related term are showing as below:
DHA:ORIONPHARM'
s OCF Yield % Range Over the Past 10 Years
Min: 3.32 Med: 14.69 Max: 35.27
Current: 11.44
During the past 12 years, the highest OCF Yield % of Orion Pharma was 35.27%. The lowest was 3.32%. And the median was 14.69%.
DHA:ORIONPHARM's OCF Yield % is ranked better than 59.68% of 439
companies
in the Utilities - Independent Power Producers industry
Industry Median: 8.02
vs DHA:ORIONPHARM: 11.44
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Orion Pharma OCF Yield % Related Terms
Orion Pharma OCF Yield % Historical Data
* Premium members only.
The historical data trend for Orion Pharma's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:ORIONPHARM vs CEG, VST, NRG: OCF Yield % Comparison
For the Utilities - Independent Power Producers subindustry, Orion Pharma's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Pharma OCF Yield % vs Utilities - Independent Power Producers Industry
For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Orion Pharma's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Pharma (DHA:ORIONPHARM) has a OCF Yield % of 11.44 as of Jul. 12, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Orion Pharma and its competitors. This is 22% below median its historical median of 14.69. Over the past decade, Orion Pharma's OCF Yield % has ranged from 3.32 to 35.27. According to the industry distribution chart, Orion Pharma ranks #177 out of 439 companies in the Utilities - Independent Power Producers industry, placing it in the top 40.3%.
Is Orion Pharma's OCF Yield % too high?
Orion Pharma's current OCF Yield % of 11.44 is 22% below median its 10-year median of 14.69. Over the past 10 years, this metric has ranged from a low of 3.32 to a high of 35.27. The Utilities - Independent Power Producers industry median OCF Yield % is 8.02. Orion Pharma's value of 11.44 is 42.6% above this industry median. Based on the distribution chart, Orion Pharma ranks #177 out of 439 companies in the Utilities - Independent Power Producers industry, which is above the industry midpoint. Overall, Orion Pharma has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Orion Pharma's OCF Yield % compare to CEG and VST?
According to the Utilities - Independent Power Producers industry distribution chart, Orion Pharma ranks #177 out of 439 companies for OCF Yield %. This puts Orion Pharma in the upper half of its industry. The industry median OCF Yield % is 8.02. Orion Pharma's value of 11.44 is 42.6% above this benchmark. Historically, Orion Pharma's own OCF Yield % has ranged from 3.32 to 35.27 over the past decade. While the company's 10-year median is 14.69 vs. the industry median of 8.02, Orion Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for an Utilities - Independent Power Producers company?
The median OCF Yield % among Utilities - Independent Power Producers companies is 8.02, based on 439 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orion Pharma's current OCF Yield % of 11.44 is 42.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Orion Pharma and its competitors. For the Utilities - Independent Power Producers industry, the median OCF Yield % is 8.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orion Pharma's current OCF Yield % is 11.44, which is 22% below median its own 10-year median of 14.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Pharma stock overvalued right now?
Based on GuruFocus' analysis, Orion Pharma (DHA:ORIONPHARM) is currently considered Significantly Overvalued. The stock's GF Value™ is BDT20.19, compared to a current price of BDT30.80 — trading 52.6% above its estimated fair value. The current OCF Yield % is 11.44, which is 22% below median its 10-year median of 14.69 and 42.6% above the Utilities - Independent Power Producers industry median of 8.02. Orion Pharma's overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Orion Pharma (DHA:ORIONPHARM), the current OCF Yield % is 11.44 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orion Pharma (DHA:ORIONPHARM) Overvalued in 2026?
Based on GuruFocus' analysis, Orion Pharma stock appears to be overvalued.
The current stock price of BDT30.80 is trading 52.6% above its estimated GF Value™ of BDT20.19.
GuruFocus considers Orion Pharma to be Significantly Overvalued.
Key valuation signals for DHA:ORIONPHARM:
OCF Yield %: 11.44 (22% below median its 10-year median of 14.69)
GF Value™: BDT20.19 vs. price of BDT30.80 (52.6% above fair value)
Industry Position: 42.6% above the Utilities - Independent Power Producers median (#177 of 439)
No single metric tells the full story. See the DHA:ORIONPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orion Pharma Ltd is a pharmaceutical company engaged in the creation and discovery, development, manufacturing, and marketing of pharmaceutical products, including vaccines and health-related consumer products. The company produces diversified dosage forms such as tablets, capsules, syrups, solutions, suspensions, powder for suspensions, creams, ointments, and injections under therapeutic categories including cardiovascular, antiulcerant, antiasthmatic, antihistamine, NSAIDs, antibiotic, antifungal, laxatives, anticancer, vitamins, and minerals. In addition, the company is involved in power generation activities and generates maximum revenue from pharmaceutical activities. The group principally carries out its business operations and markets its products in Bangladesh.
71GF Score
Get the complete analysis for DHA:ORIONPHARM
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:ORIONPHARM has been successfully added to your 
